Provided by Tiger Fintech (Singapore) Pte. Ltd.

Reviva Pharmaceuticals Holdings, Inc.

0.8900
+0.01301.48%
Post-market: 0.8686-0.0214-2.40%17:45 EDT
Volume:252.43K
Turnover:215.13K
Market Cap:41.60M
PE:-0.99
High:0.8900
Open:0.8900
Low:0.8276
Close:0.8770
Loading ...
Apr 03, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Apr 03, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 31, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Major Issues Report

Form 8-K - Current report
Dec 18, 2024

Major Issues Report

Form 8-K - Current report
Dec 16, 2024

Major Issues Report

Form 8-K - Current report
Dec 12, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Sep 17, 2024

Major Issues Report

Form 8-K - Current report
Aug 23, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 23, 2024

Beneficial Ownership Change

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
Aug 22, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Aug 21, 2024

Major Issues Report

Form 8-K - Current report
Aug 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Aug 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 14, 2024

Major Issues Report

Form 8-K - Current report